(Bentsen, Miaskowski, & Rustøen, 2014)

100 patients

Cross-sectional study

NA

SGRQ

Age, Anxiety score

Number of comorbidities, Pain intensity, Depression score, Physical functions, GOLD Spirometrics staging, FEV1 % Predicted

(Bonsaksen, Haukeland-Parker, Lerdal, & Fagermoen, 2014)

127 patients

Prospective longitudinal design

12 months after course completion

Short Form 12, version 2 (SF-12v2), SF-36.

Work status, Illness perception

Age, Sex, Education, Physical activity, Self-efficacy

(Negi, Sarkar, Raval, Pandey, & Das, 2014)

126 patients

A cross-sectional study

Between November 2011 and April 2012

Hindi version of SGRQ

BMI, FEV1% predicted, FEV1/FVC%, MRC Dyspnea grade, Education, GOLD stage

Age, Sex, Area of residence, Smoking index, Seasonal variation

(Raherison et al., 2014)

430 patients

A multicenter cross-sectional observational study

September 2009 to November 2010

SGRQ-C

MRC dyspnea score, Number of treatments, Age, Anxiety, FEV1% predicted

Gold stage, Age, FEV1/FVC, BOD Index, No of exacerbation

(Abu Hassan, Abd Aziz, Hassan, & Hassan, 2014)

117 patients

NA

January to June 2013

CCQ

Smoking status, No of hospital admission due to COPD

No of days warded

(Justine, Tahirah, & Mohan, 2013)

100 patients

Cross-sectional correlational study

NA

SF-36 v2

Dyspnea score

Lung function

(Bentsen, Rokne, & Wahl, 2013)

100 COPD patients and 3594 general population

A comparative survey design

Between August 2005 and August 2007.

SF-36

COPD stage and severity

Age, Sex, Education level

(Obaseki, Erhabor, Awopeju, Obaseki, & Adewole, 2013)

50 patients

a cross-sectional study

NA

SGRQ

Breathlessness, Weight loss, Smoking pack /year

Age, Sex, Smoking status, GOLD stage, FEV1/FVC %, BMI

(Burgel et al., 2013)

326 patients

Cross-sectional analysis

Between January 2005 and August 2009.

HADS

SGRQ

FEV1%, Exacerbation/patient/year, Dyspnea, Low BMI, CAD/Comorbidity

Age, Smoking pack/year, Comorbidities, Current smokers, Sex

(Zamzam, Azab, El Wahsh, Ragab, & Allam, 2012)

40 patients

NA

NA

SGRQ

GOLD stage, FEV1% predicted

Smoking index

(Joseph, Pascale, Georges, & Mirna, 2012)

284 COPD patients from 2201 total sample

Cross-sectional study

Between October 2009 and September 2010

CCQ

Cumulative cigarette dose, Older age, having at least one smoker in the family, Lower education, Female gender, Any heart disease, Heating house by diesel, Cumulative waterpipe dose

COPD severity scoring

(Han et al., 2011)

224 African American and 1049 Caucasian subjects with COPD

Descriptive design

NA

SGRQ

Pack-year smoking history, Younger age, Lower FEV 1% predicted, mMRC, The number of exacerbations

Race

(Sundh, Ställberg, Lisspers, Montgomery, & Janson, 2011)

1548 patients

Survey design/different setting

In 2005

CCQ

Educational level, BMI, Heart disease, GOLD stage

Sex, Age, Smoking status, comorbidities